SEOUL, September 26 (AJP) - U.S. President Donald Trump's comments linking Tylenol use during pregnancy to autism have rattled some expectant mothers in South Korea, sparking anxiety and anger, while Korean health authorities firmly denied any scientific connection.
At a White House press conference Monday, Trump said he would direct the U.S. Food and Drug Administration (FDA) to restrict acetaminophen-based medicines such as Tylenol during pregnancy, except in cases of severe need such as high fever. He cited statistics showing autism prevalence in the U.S. has risen nearly fourfold since 2000, urging pregnant women and children to avoid the drug altogether.
Tylenol's manufacturer, Kenvue, rejected the claim, stressing that scientific studies have found no causal link between acetaminophen and autism.
In Korea, the remarks unsettled some mothers-to-be.
"I've taken two Tylenol tablets recently," said Ryu Ji-yeon, 31, who is in her 31st week of pregnancy. "I'm a little nervous after hearing the report, even though the authorities say it is safe."
Others expressed frustration.
"Pregnant women already endure constant pain and take Tylenol only when it's truly necessary, but such uncertain claims make mothers feel guilty," said Ko Hye-ri, also 31 weeks pregnant. "Some may even avoid taking it despite having a high fever, which could pose greater risks to the baby."
For many, however, the news barely registered.
"I've taken Tylenol for headaches but didn't feel concerned," said Choi Young-hee, 35, in her 32nd week. "It's basically the only pain reliever available in pregnancy, and I've read experts saying there's no link to autism."
Several other women echoed that view, noting they trusted doctors' guidance and that untreated pain or fever could be more harmful than the medication itself. Tylenol, some said, is practically seen as the "pregnancy medicine."
Korea's Ministry of Food and Drug Safety on Thursday reiterated that acetaminophen can be used safely during pregnancy under medical supervision. It stressed there is no evidence linking the drug to autism, while recommending that daily intake stay below 4,000 milligrams and be guided by a physician's advice.
The Korean Pharmaceutical Association and the World Health Organization have both emphasized that acetaminophen is a well-established, safe option for pregnant women when used appropriately.
Autism diagnoses have also risen in Korea. Government data show the number of registered individuals with autism spectrum disorders rose nearly 40 percent, from about 26,700 in 2018 to more than 37,000 in 2022. Experts note the increase may reflect not only actual growth in cases but also broader diagnostic criteria and more families registering for government support. More recent data have yet to be released.
reporter
Cheon Soram
cheons@ajupress.com
Copyright ⓒ Aju Press All rights reserved.
